Trends and outcomes of fungal infections in hospitalized patients of inflammatory bowel disease: a nationwide analysis Article (Faculty180)

cited authors

  • Mushtaq, Kamran; Khan, Zubair; Aziz, Muhammad; Alyousif, Z A; Siddiqui, Nauman; Khan, Muh A; Nawras, Ali


  • Immunosuppressive therapy is being increasingly used in the management of inflammatory bowel disease (IBD) which comprises of ulcerative colitis (UC) and Crohn's disease (CD). Patients on immunosuppressive therapy are at increased risk of developing opportunistic fungal infections. We conducted this analysis to describe the epidemiology of opportunistic fungal infections in this cohort.


publication date

  • 2020

start page

  • 35


  • 5